跳至主要内容
临床试验/IRCT138801231808N1
IRCT138801231808N1已完成2 期

Clinical Efficacy of Piracetam on the Treatment of Breath _Holding Spells

Mazandaran University of Medical Sciences and Health Services0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 year 至 3 years(—)
性别
All

入选标准

  • 1) History of breath- Holding spell and physical and neurological examination by pediatric neurologist. 2) Minimum age 6 month and maximum 3 years old 3) Normal EEG 4) absent of systematic disease 5) Normal growth and Development 6) No history of epilepsy in family member 7) No Electrolyte Abnormality (Hypoglycemia and Hypocalcaemia )
  • Exclusion criteria: 1) Children with history of convulsion 2) Children that received Anticonvulsant drugs. 3) Delayed neurotic development 4) all Children with heart diseases 5) all children with anemia 6) Side effects of priacetam including true dizziness, convulsion, extra pyramidal sings, lethargy, headache, sleepy; gastrointestinal complication including nausea and vomiting, diarrhea, constipation, anorexia, increased weight

排除标准

  • 未提供

研究者

发起方
Mazandaran University of Medical Sciences and Health Services

相似试验

Clinical Efficacy of Piracetam on the Treatment of... | 临床试验